Covid antiviral drug Molnupiravir has 'major safety concerns': ICMR

Flagging the various health concerns surrounding the Covid anti-viral drug Molnupiravir, ICMR’s Dr Balram Bhargava said that Merck’s coronavirus pill has not been added to the national treatment protocol due to some ‘major safety concerns.’

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3F45Gkg
via IFTTT